Linden Thomas Advisory Services LLC reduced its stake in Perrigo Company plc (NYSE:PRGO – Free Report) by 4.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,983 shares of the company’s stock after selling 852 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Perrigo were worth $488,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC boosted its stake in Perrigo by 2.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 21,617 shares of the company’s stock valued at $567,000 after acquiring an additional 436 shares during the period. Voisard Asset Management Group Inc. boosted its position in shares of Perrigo by 9.7% during the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock worth $134,000 after buying an additional 450 shares during the period. Central Pacific Bank Trust Division boosted its position in shares of Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock worth $51,000 after buying an additional 500 shares during the period. Creative Planning boosted its position in shares of Perrigo by 3.7% during the third quarter. Creative Planning now owns 18,477 shares of the company’s stock worth $485,000 after buying an additional 661 shares during the period. Finally, KBC Group NV boosted its position in shares of Perrigo by 25.1% during the third quarter. KBC Group NV now owns 4,517 shares of the company’s stock worth $118,000 after buying an additional 905 shares during the period. 95.91% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Perrigo
In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.70% of the stock is owned by corporate insiders.
Perrigo Price Performance
Perrigo (NYSE:PRGO – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting the consensus estimate of $0.81. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.64 earnings per share. Equities research analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.
Perrigo Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th were issued a $0.276 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $1.10 annualized dividend and a dividend yield of 4.48%. Perrigo’s dividend payout ratio is currently -94.02%.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on PRGO. Canaccord Genuity Group reiterated a “buy” rating and set a $42.00 price objective on shares of Perrigo in a research report on Monday, September 30th. Argus downgraded Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a research report on Saturday, January 11th. Finally, Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $35.00.
View Our Latest Research Report on Perrigo
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles
- Five stocks we like better than Perrigo
- The Basics of Support and Resistance
- MP Materials: Rare Earth Elements Powering the EV Boom
- Technology Stocks Explained: Here’s What to Know About Tech
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is the S&P/TSX Index?
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.